|
|
|
Financials-Cipla Limited| Sector: Bulk Drugs and Formulations | | BSE:500087 | NSE:CIPLA | Bloomberg:CIPLA@IN | Reuters:CIPL.BO | | Market Lot: 1 | Face Value: 2 | ISIN Demat: INE059A01026 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2021(3) |
| Sales of Products/Services |
32331.20 |
32331.20 |
| Other Operating Income |
0.00 |
0.00 |
| Other Income |
493.30 |
493.30 |
| Total Income |
32824.50 |
32824.50 |
| Total Expenses |
-27292.70 |
-27292.70 |
| OPBDIT |
60117.20 |
60117.20 |
| Interest |
0.00 |
0.00 |
| Depreciation |
-1370.10 |
-1370.10 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
| Prior Period Adjustments |
0.00 |
0.00 |
| Provision for Tax |
-1397.70 |
-1397.70 |
| After Tax Profit |
4134.10 |
4134.10 |
| Equity Capital |
0.00 |
0.00 |
| Reserves |
0.00 |
0.00 |
| Notes to Accounts |
|
|
|
| As on( Months ) |
31-Mar-08(12) |
|
31-Mar-07(12) |
|
31-Mar-06(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
39979.00 |
94.08 |
34382.40 |
95.40 |
28974.10 |
93.18 |
| Operating Income (OI) |
42496.10 |
100.00 |
36040.90 |
100.00 |
31094.00 |
100.00 |
| OPBDIT |
8984.90 |
21.14 |
8578.10 |
23.80 |
8219.40 |
26.43 |
| OPBDT |
9475.20 |
22.30 |
8796.30 |
24.41 |
7952.90 |
25.58 |
| OPBT |
8168.40 |
19.22 |
7762.60 |
21.54 |
7151.10 |
23.00 |
| Non-Operating Income |
215.20 |
0.51 |
317.20 |
0.88 |
-52.70 |
-0.17 |
| Extraordinary/Prior Period |
-365.00 |
-0.86 |
-147.00 |
-0.41 |
-90.00 |
-0.29 |
| Tax |
1004.30 |
2.36 |
1252.50 |
3.48 |
932.00 |
3.00 |
| Profit after tax(PAT) |
7014.30 |
16.51 |
6680.30 |
18.54 |
6076.40 |
19.54 |
| Cash Profit |
8321.10 |
19.58 |
7714.00 |
21.40 |
6878.20 |
22.12 |
| Dividend-Equity |
1554.60 |
3.66 |
1554.60 |
4.31 |
1554.60 |
5.00 |
|
| As on |
31-Mar-08 |
|
31-Mar-07 |
|
31-Mar-06 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
21928.20 |
38.31 |
17907.40 |
40.65 |
13573.50 |
39.35 |
| Net Block |
16523.90 |
28.87 |
13791.00 |
31.31 |
10472.90 |
30.36 |
| Capital WIP |
2331.20 |
4.07 |
731.90 |
1.66 |
870.10 |
2.52 |
| Investments |
12.70 |
0.02 |
12.70 |
0.03 |
0.00 |
0.00 |
| Inventory |
11204.90 |
19.57 |
9786.00 |
22.22 |
9570.00 |
27.75 |
| Receivables |
13939.10 |
24.35 |
10287.80 |
23.36 |
8759.60 |
25.40 |
| Other Current Assets |
13230.60 |
23.11 |
9438.30 |
21.43 |
4817.50 |
13.97 |
| Balance Sheet Total(BT) |
57242.40 |
100.00 |
44047.70 |
100.00 |
34490.10 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
1554.60 |
2.72 |
1554.60 |
3.53 |
599.70 |
1.74 |
| Reserves |
35913.90 |
62.74 |
30718.40 |
69.74 |
19139.80 |
55.49 |
| Total Debt |
5805.30 |
10.14 |
1235.60 |
2.81 |
4689.10 |
13.60 |
| Creditors and Acceptances |
5335.10 |
9.32 |
3059.30 |
6.95 |
3712.70 |
10.76 |
| Other current liab/prov. |
8633.50 |
15.08 |
7479.80 |
16.98 |
6348.80 |
18.41 |
| Balance Sheet Total(BT) |
57242.40 |
100.00 |
44047.70 |
100.00 |
34490.10 |
100.00 |
|
| As on |
31-Mar-08 |
31-Mar-07 |
31-Mar-06 |
| OPBIT/Prod.cap.empl.(%) |
19.97 |
23.89 |
31.81 |
| PBIT/Cap. Employed (%) |
18.39 |
23.54 |
30.88 |
| PAT/Networth (%) |
18.72 |
20.70 |
30.78 |
| Tax/PBT (%) |
12.52 |
15.79 |
13.30 |
| Total Debt/Networth (x) |
0.15 |
0.04 |
0.24 |
| Long Term Debt/Networth (x) |
0.15 |
0.04 |
0.21 |
| PBDIT/Finance Charges (x) |
-18.02 |
-40.09 |
30.31 |
| Current Ratio (x) |
2.75 |
2.80 |
2.30 |
| RM Inventory (days consumption) |
174.58 |
189.12 |
188.89 |
| FG inventory (days cost of sales) |
36.48 |
40.78 |
54.74 |
| Receivables (days gross sales) |
124.44 |
106.28 |
105.88 |
| Creditors (days cost of sales) |
58.11 |
40.66 |
59.24 |
| Op. curr. assets (days OI) |
307.00 |
287.00 |
269.00 |
|
|
Financials